Actinium Pharmaceuticals, Inc. (ATNM)
R&D Expense Growth
-29.69%
Fiscal year · Period ending:
ATNM R&D Expense Growth
Latest reported-29.69%period ending
Latest reported-29.69%period ending
ATNM FY R&D Growth (YoY) (0.00% → -29.69%)
Latest values, visible window
High-resolution chart · PNG
ATNM r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -29.6921% | |
| -22.3041% | |
| 67.1493% | |
| 32.1471% | |
| 8.8405% | |
| -2.8079% | |
| -3.1899% | |
| -3.4181% | |
| 1.1371% | |
| 31.4678% | |
| 8.5188% | |
| 359.955% | |
| -22.4709% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |